DK0744957T3 - Præparat og fremgangsmåde til forebyggelse og behandling af inflammation med immunoglobulin A - Google Patents

Præparat og fremgangsmåde til forebyggelse og behandling af inflammation med immunoglobulin A

Info

Publication number
DK0744957T3
DK0744957T3 DK95909729T DK95909729T DK0744957T3 DK 0744957 T3 DK0744957 T3 DK 0744957T3 DK 95909729 T DK95909729 T DK 95909729T DK 95909729 T DK95909729 T DK 95909729T DK 0744957 T3 DK0744957 T3 DK 0744957T3
Authority
DK
Denmark
Prior art keywords
inflammation
preparation
immunoglobulin
prevention
treatment
Prior art date
Application number
DK95909729T
Other languages
Danish (da)
English (en)
Inventor
Martha Prof Eibl
Herrmann Dr Wolf
Josef W Mannhalter
Heinz Dr Leibl
Yendra Dr Linnau
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22731867&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0744957(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Immuno Ag filed Critical Immuno Ag
Application granted granted Critical
Publication of DK0744957T3 publication Critical patent/DK0744957T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/861—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgG3, IgG4, IgA, or IgY
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK95909729T 1994-02-18 1995-02-16 Præparat og fremgangsmåde til forebyggelse og behandling af inflammation med immunoglobulin A DK0744957T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19806794A 1994-02-18 1994-02-18
PCT/EP1995/000571 WO1995022350A1 (fr) 1994-02-18 1995-02-16 Composition et procede destines a prevenir et traiter les inflammations a l'aide d'immunoglobuline a

Publications (1)

Publication Number Publication Date
DK0744957T3 true DK0744957T3 (da) 2000-03-06

Family

ID=22731867

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95909729T DK0744957T3 (da) 1994-02-18 1995-02-16 Præparat og fremgangsmåde til forebyggelse og behandling af inflammation med immunoglobulin A

Country Status (12)

Country Link
US (1) US5833984A (fr)
EP (1) EP0744957B1 (fr)
JP (1) JPH09509164A (fr)
AT (2) ATE182793T1 (fr)
AU (1) AU1809495A (fr)
CA (1) CA2183566A1 (fr)
DE (2) DE69511245T2 (fr)
DK (1) DK0744957T3 (fr)
ES (1) ES2135703T3 (fr)
GR (1) GR3031691T3 (fr)
IT (1) IT1281188B1 (fr)
WO (1) WO1995022350A1 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN115095A0 (en) * 1995-02-15 1995-03-09 Butt, Henry Lawrence Analysis of and compositions and methods for the treatment of disease
DE19600939C1 (de) * 1996-01-12 1997-08-28 Immuno Ag Verfahren zur Trennung von IgG und IgA
US6344545B1 (en) * 1996-06-14 2002-02-05 Progenics Pharmaceuticals, Inc. Method for preventing HIV-1 infection of CD4+ cells
EP0839915A1 (fr) * 1996-11-01 1998-05-06 Institut Suisse De Recherches Experimentales Sur Le Cancer Isrec Immunoglobuline A sécrétoire comme système d'administration de vaccins mucosales
US20020114802A1 (en) * 1998-02-10 2002-08-22 Tjellstrom Bo Arthur Einar Oral immunoglobulin treatment for inflammatory bowel disease
CA2370268A1 (fr) * 1999-04-19 2000-10-26 Richard Weisbart Traitement de la polyarthrite rhumatoide de l'adulte par l'administration orale d'immunoglobuline humaine provenant d'un pool de donneurs et d'un antiacide
CA2423805A1 (fr) * 2000-09-28 2002-04-04 Richard Weisbart Traitement des maladies d'origine immunologique au moyen de l'administration par voie orale de fractions de plasma enrichies en immunoglobuline g
US20020098182A1 (en) * 2000-09-28 2002-07-25 Richard Weisbart Treatment of immune-mediated diseases by oral administration of plasma fractions enriched in immunoglobulin G
CA2424623A1 (fr) * 2000-10-06 2002-04-11 Richard Weisbart Traitement de l'arthrite rhumatoide juvenile par administration orale d'un pool d'immunoglobuline humaine et d'un antiacide
US20040180045A1 (en) * 2001-09-28 2004-09-16 Richard Weisbart Treatment of immune-mediated diseases by oral administration of plasma fractions enriched in immunoglobulin G
US7344716B2 (en) * 2003-05-13 2008-03-18 Depuy Spine, Inc. Transdiscal administration of specific inhibitors of pro-inflammatory cytokines
US7429378B2 (en) * 2003-05-13 2008-09-30 Depuy Spine, Inc. Transdiscal administration of high affinity anti-MMP inhibitors
US7553827B2 (en) * 2003-08-13 2009-06-30 Depuy Spine, Inc. Transdiscal administration of cycline compounds
US20040229878A1 (en) * 2003-05-13 2004-11-18 Depuy Spine, Inc. Transdiscal administration of specific inhibitors of P38 kinase
US8273347B2 (en) 2003-05-13 2012-09-25 Depuy Spine, Inc. Autologous treatment of degenerated disc with cells
US8361467B2 (en) * 2003-07-30 2013-01-29 Depuy Spine, Inc. Trans-capsular administration of high specificity cytokine inhibitors into orthopedic joints
US8895540B2 (en) * 2003-11-26 2014-11-25 DePuy Synthes Products, LLC Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor
US20060057223A1 (en) * 2004-09-10 2006-03-16 Dimauro Thomas M Intradiscal production of autologous interleukin antagonist
US20110020291A1 (en) * 2007-11-17 2011-01-27 Debrabrata Banerjee Use of stem cells for wound healing
US8986696B2 (en) 2007-12-21 2015-03-24 Depuy Mitek, Inc. Trans-capsular administration of p38 map kinase inhibitors into orthopedic joints
US20090162351A1 (en) * 2007-12-21 2009-06-25 Depuy Spine, Inc. Transdiscal administration of inhibitors of p38 MAP kinase
US10716850B2 (en) 2014-12-31 2020-07-21 Wellin, Inc. Anti-inflammatory factor retentate, method of isolation, and use
CN114894911B (zh) * 2022-03-18 2023-10-24 辽宁成大生物股份有限公司 一种控制牛血清产品质量方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5837285B2 (ja) * 1975-05-29 1983-08-15 カブシキガイシヤ ミドリジユウジ チヨウナイカンセンシヨウチリヨウザイノセイゾウホウホウ
JPS5653622A (en) * 1979-10-09 1981-05-13 Mochida Pharmaceut Co Ltd Preventive and remedy for infectious disease of respiratory organ and oral cavity
JPS5759815A (en) * 1980-09-30 1982-04-10 Mochida Pharmaceut Co Ltd Drug composition having preventing and remedying action on rotavirus infectious disease
DE3927111C3 (de) * 1989-08-17 1994-09-01 Biotest Pharma Gmbh Verfahren zur Herstellung nicht modifizierter intravenös verabreichbarer IgM- und/oderIgA-haltiger Immunglobulinpräparate
JP3145696B2 (ja) * 1990-10-05 2001-03-12 日本ケミカルリサーチ株式会社 分泌型免疫グロブリンａ製剤の製造法
AT402789B (de) * 1991-03-25 1997-08-25 Immuno Ag Pharmazeutische präparation auf basis von plasmaproteinen

Also Published As

Publication number Publication date
DE19505287A1 (de) 1995-08-24
EP0744957A1 (fr) 1996-12-04
AU1809495A (en) 1995-09-04
JPH09509164A (ja) 1997-09-16
ITTO950112A0 (it) 1995-02-17
CA2183566A1 (fr) 1995-08-24
AT402790B (de) 1997-08-25
EP0744957B1 (fr) 1999-08-04
DE69511245D1 (de) 1999-09-09
WO1995022350A1 (fr) 1995-08-24
DE69511245T2 (de) 1999-12-16
ITTO950112A1 (it) 1996-08-17
IT1281188B1 (it) 1998-02-17
ATE182793T1 (de) 1999-08-15
ATA29495A (de) 1997-01-15
US5833984A (en) 1998-11-10
GR3031691T3 (en) 2000-02-29
ES2135703T3 (es) 1999-11-01

Similar Documents

Publication Publication Date Title
DK0744957T3 (da) Præparat og fremgangsmåde til forebyggelse og behandling af inflammation med immunoglobulin A
BG95935A (bg) Метод и средство за приемане на дексмедетомидин директно през кожата
PT914114E (pt) Metodos de tratamento de hipersensibilidade de tipo i utilizando monofosforil lipido a
FI904092A7 (fi) Lääkevalmisteita ankarien kiputilojen käsittelyyn ja menetelmä niiden valmistamiseksi
DK0713701T3 (da) 2-Brommelatonin til behandling af søvnforstyrrelser
FI923548A7 (fi) Vaahtoa muodostava koostumus farmaseuttiseen käyttöön, sen käyttö ja h oitomenetelmä
NZ241210A (en) 16alpha,17alpha-butylidenedioxy-11b, 21-dihydroxypregn-4-ene-3,20-dione derivatives substituted in either or both the 6alpha- and 9alpha- positions by fluorine; pharmaceutical compositions, methods of preparation and treatment
FI970747A0 (fi) Yhdistelmävalmiste käytettäväksi immunologisissa sairauksissa
DK1153610T3 (da) Matrixproteinpræparater til inflammatoriske og infektiøse tilstande
FR2706305B1 (fr) Composition cosmétique ou pharmaceutique anti-radicaux libres pour application topique.
NO894222D0 (no) Fremgangsmaater for behandling av profylakse av pneumocytis carinii pneumoni og andre sykdommer og forbindelser og formuleringer til anvendelse i nevnte metoder.
IT9067434A0 (it) Procedimento per migliorare l'efficacia terapeutica di corticosteroidi liposolubili e composizione per l'attuazione di tale procedimento
EA199800717A1 (ru) Способ лечения заболеваний млекопитающих и цвиттерионная композиция
FI944561L (fi) HIV:tä neutraloivia monoklonaalisia yhdistelmähumaanivasta-aineita HIV-infektion ehkäisemiseksi ja hoitamiseksi
DK0817646T3 (da) Fremgangsmåder til behandling af inflammation og præparater derfor
DK0579488T3 (da) Præparat til behandling af mastitis og matritis
SE9601395D0 (sv) New therapeutic treatment 1
FI956353L (fi) Farmaseuttiset valmisteet ja niiden käyttö etenkin neurodegeneratiivisten sairauksien hoidossa
FI944687L (fi) Koostumus likinäköisyyden ennaltaehkäisemiseksi ja hoitamiseksi
FI883723A7 (fi) Ihmisen monoklonaaliset vasta-aineet ja niitä vaikuttavana aineosana s isältävät terapeuttiset aineet infektiotauteja vastaan
ATE189395T1 (de) Verwendung von protease nexin-i als mittel gegen entzündungen
DE59101818D1 (de) Arzneimittelzubereitung, enthaltend Stigmasta-4-en-3-on sowie deren Verwendung.
FI942941L (fi) Humaaniproteiini C:n käyttö trombosyyttien saostumisen estämiseen ja hoitoon
DK0621789T3 (da) Farmaceutiske pentapeptidpræparater og fremgangsmåder til anvendelse deraf
WO1999065511A3 (fr) COMPOSITION ET PROCEDE DE TRAITEMENT D'UNE INFECTION PAR $i(PSEUDOMONAS)